Logo image of NUWE

NUWELLIS INC (NUWE) Stock Price, Quote, News and Overview

NASDAQ:NUWE - Nasdaq - US67113Y6032 - Common Stock - Currency: USD

1.11  -0.05 (-4.31%)

NUWE Quote, Performance and Key Statistics

NUWELLIS INC

NASDAQ:NUWE (1/29/2025, 2:33:21 PM)

1.11

-0.05 (-4.31%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High27.61
52 Week Low0.92
Market Cap4.85M
Shares4.37M
Float4.34M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO02-16 2012-02-16


NUWE short term performance overview.The bars show the price performance of NUWE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40

NUWE long term performance overview.The bars show the price performance of NUWE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NUWE is 1.11 USD. In the past month the price increased by 1.31%. In the past year, price decreased by -93.1%.

NUWELLIS INC / NUWE Daily stock chart

NUWE Latest News, Press Releases and Analysis

News Image
16 days ago - Nuwellis, Inc.

Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy

MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people...

News Image
a month ago - Benzinga

FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device

The FDA and Nuwellis warn of potential risks linked to AquaFlexFlow UF 500 Plus blood circuits. A recall addresses issues like therapy termination and patient injury risks.

News Image
a month ago - Nuwellis, Inc.

Nuwellis Regains Compliance with Nasdaq Listing Requirements

MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (the “Company” or “Nuwellis”) today announced that the Company received...

News Image
3 months ago - Nuwellis, Inc.

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with...

News Image
3 months ago - Nuwellis, Inc.

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company...

NUWE Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.45 222.38B
ISRG INTUITIVE SURGICAL INC 78.39 204.65B
BSX BOSTON SCIENTIFIC CORP 43.49 151.26B
SYK STRYKER CORP 32.16 149.47B
MDT MEDTRONIC PLC 17.52 117.93B
BDX BECTON DICKINSON AND CO 18.78 71.66B
EW EDWARDS LIFESCIENCES CORP 26.82 42.23B
GEHC GE HEALTHCARE TECHNOLOGY 20.81 40.12B
RMD RESMED INC 30.24 36.81B
IDXX IDEXX LABORATORIES INC 37.74 33.83B
DXCM DEXCOM INC 50.68 33.65B
PHG KONINKLIJKE PHILIPS NVR- NY 20.41 25.71B

About NUWE

Company Profile

NUWE logo image Nuwellis Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Eden Prairie, Minnesota and currently employs 59 full-time employees. The company went IPO on 2012-02-16. Nuwellis, Inc. is a medical technology company. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Company Info

NUWELLIS INC

12988 Valley View Rd

Eden Prairie MINNESOTA 55344 US

CEO: Nestor Jaramillo

Employees: 59

Company Website: https://www.nuwellis.com/

Investor Relations: http://ir.sunshineheart.com/

Phone: 19523454200

NUWE FAQ

What is the stock price of NUWE?

The current stock price of NUWE is 1.11 USD.


What is the symbol for NUWELLIS INC stock?

The exchange symbol of NUWELLIS INC is NUWE and it is listed on the Nasdaq exchange.


On which exchange is NUWE stock listed?

NUWE stock is listed on the Nasdaq exchange.


Is NUWE a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NUWE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NUWE.


Does NUWE stock pay dividends?

NUWE does not pay a dividend.


What is the Price/Earnings (PE) ratio of NUWE?

NUWE does not have a PE ratio as the earnings reported over the last twelve months were negative (-92.71).


What is the Short Interest ratio of NUWE stock?

The outstanding short interest for NUWE is 7.78% of its float.


NUWE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to NUWE. When comparing the yearly performance of all stocks, NUWE is a bad performer in the overall market: 96.65% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NUWE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NUWE. The financial health of NUWE is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NUWE Financial Highlights

Over the last trailing twelve months NUWE reported a non-GAAP Earnings per Share(EPS) of -92.71. The EPS increased by 83.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -253.91%
ROE -537.37%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%102.75%
Sales Q2Q%-1.87%
EPS 1Y (TTM)83.67%
Revenue 1Y (TTM)3.57%

NUWE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to NUWE. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 94.66% and a revenue growth 0.2% for NUWE


Ownership
Inst Owners1.08%
Ins Owners0.01%
Short Float %7.78%
Short Ratio0.11
Analysts
Analysts80
Price Target16.32 (1370.27%)
EPS Next Y94.66%
Revenue Next Year0.2%